Literature DB >> 17922945

The application of probiotics in cancer.

Alejandra de Moreno de LeBlanc1, Chantal Matar, Gabriela Perdigón.   

Abstract

Lactic acid bacteria (LAB) are present in many foods such as yoghurt and are frequently used as probiotics to favour some biological functions in the host. Many investigators have evaluated the therapeutic effects of yoghurt and LAB commonly used in yoghurt production against diseases such as cancer, infection, and gastrointestinal disorders. The increase of immune cell activity in the prevention of cancer by LAB consumption has also been described. Another possible explanation for the preventive effect of probiotics on carcinogenesis is their effect on other bacteria in the intestine. Probiotics may suppress the growth of bacteria that convert procarcinogens into carcinogens, thereby reducing the amount of carcinogens in the intestine. The present review is focused on two types of cancer in which milk fermented by LAB may show a beneficial effect: colon cancer and breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922945     DOI: 10.1017/S0007114507839602

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  17 in total

Review 1.  When human cells meet bacteria: precision medicine for cancers using the microbiota.

Authors:  Han Zhang; Litao Sun
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 2.  Modification in the diet can induce beneficial effects against breast cancer.

Authors:  Felix Aragón; Gabriela Perdigón; Alejandra de Moreno de LeBlanc
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Evolving Roles of Probiotics in Cancer Prophylaxis and Therapy.

Authors:  Seema Patel; Arun Goyal
Journal:  Probiotics Antimicrob Proteins       Date:  2013-03       Impact factor: 4.609

Review 4.  Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

Authors:  Murphy L Y Wan; Hani El-Nezami
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

Review 5.  Gut bacteria and cancer.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Biochim Biophys Acta       Date:  2015-06-04

6.  Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  F Higashikawa; M Noda; T Awaya; N Danshiitsoodol; Y Matoba; T Kumagai; M Sugiyama
Journal:  Eur J Clin Nutr       Date:  2016-03-09       Impact factor: 4.016

Review 7.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

8.  The obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat diet-induced obese mice.

Authors:  Xingrong Zhao; Fumiko Higashikawa; Masafumi Noda; Yusuke Kawamura; Yasuyuki Matoba; Takanori Kumagai; Masanori Sugiyama
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 9.  Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology.

Authors:  Holly Hardy; Jennifer Harris; Eleanor Lyon; Jane Beal; Andrew D Foey
Journal:  Nutrients       Date:  2013-05-29       Impact factor: 5.717

10.  Bacillus subtilis natto: a non-toxic source of poly-γ-glutamic acid that could be used as a cryoprotectant for probiotic bacteria.

Authors:  Aditya R Bhat; Victor U Irorere; Terry Bartlett; David Hill; Gopal Kedia; Mark R Morris; Dimitris Charalampopoulos; Iza Radecka
Journal:  AMB Express       Date:  2013-07-05       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.